Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate
Clinical trial NCT00319228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00319228
- Sponsor
- Grifols Biologicals, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2028-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.